Douglass Hanly Moir Pathology
Douglass Hanly Moir Pathology is a Sonic Healthcare-owned diagnostic pathology practice operating 500+ collection centres and NATA-accredited laboratories across New South Wales and north-west Victoria, serving patients, GPs, specialists, private hospitals, and nursing homes with routine and specialty pathology testing.
- Company typePrivate
- Founded1996
- HeadquartersSydney, Australia
- Headcount501–1,000
- GTM typeB2B and B2C
- OfferingServices
What Douglass Hanly Moir Pathology does
Douglass Hanly Moir Pathology (DHM) is a privately held diagnostic pathology practice headquartered in Macquarie Park, New South Wales, and operating as a wholly owned subsidiary of the publicly listed Sonic Healthcare group (ASX: SHL). Founded in 1996, the company employs 501–1,000 staff and serves patients and referring clinicians across New South Wales and north-west Victoria through a network of more than 500 collection centres, three metropolitan laboratories, regional laboratories, and a central laboratory operating 24 hours per day, 365 days per year. Its clinical workforce comprises more than 95 pathologists covering all major pathology subdisciplines, with specialty practices branded GynaePath (gynaecological), Sonic Skin Dx (dermatopathology), Sonic Uro Dx (urological), Sonic Genetics (genetic and reproductive carrier screening), and DNALabs (parentage/relationship DNA). Patient-facing differentiation includes the Smileyscope virtual-reality headset partnership for anxiety reduction during blood draws and online appointment booking.
The company's core technology stack is NATA-accredited laboratory testing infrastructure spanning routine clinical chemistry, haematology, microbiology, immunology, anatomical pathology, and advanced molecular diagnostics including MetaPanel clinical metagenomics, non-invasive prenatal testing (NIPT), fetal Rhesus screening, pharmacogenomics (PGx), and reproductive carrier screening. Digital platforms include Sonic Dx for electronic clinician result delivery, eSupplies for pathology consumables ordering, Sonic Edu for clinician continuing-professional-development content, and integration with Australia's My Health Record system for patient access. Cardiac services (ECG, Holter monitoring, ambulatory blood pressure monitoring) are delivered through an in-house cardiologist, a less common capability within Australian pathology providers. Certifications include NATA accreditation, RCPA-guideline compliance, Medicare Benefits Schedule participating-provider status, and Australian Privacy Act compliance.
DHM's revenue model combines three streams: bulk-billed Medicare-rebatable pathology tests subject to a maximum A$210/day out-of-pocket cap for eligible outpatients; privately billed fees for non-Medicare specialist tests (e.g., Active B12 confirmatory, drug and alcohol chain-of-custody); and direct billing arrangements with four major OSHC/OSV insurers (AHM, Allianz, Bupa, Medibank Private) for international students and visitors. Commercial-pathology lines (Drug & Alcohol, Occupational Exposure, Health & Wellness, Workplace Testing) and corporate immunity screening (Measles, Mumps, Rubella, Varicella, Hepatitis B, TB at A$25–$75 per test) provide non-Medicare revenue. Customer segments fall into two primary channels — referring clinicians (GPs, specialists, private hospitals, nursing homes, community health services) routed through Sonic Dx, and patients accessing collection centres directly — with overseas students/visitors and healthcare-worker/student immunity candidates as secondary segments.
Douglass Hanly Moir Pathology firmographics
Firmographics- Name
- Douglass Hanly Moir Pathology
- Legal name
- Douglass Hanly Moir Pathology
- Website
- https://dhm.com.au
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Douglass Hanly Moir Pathology is a Sonic Healthcare-owned diagnostic pathology practice operating 500+ collection centres and NATA-accredited laboratories across New South Wales and north-west Victoria, serving patients, GPs, specialists, private hospitals, and nursing homes with routine and specialty pathology testing.
- Ownership category
- akta.pro rank
Douglass Hanly Moir Pathology industry classification
Industry- Product category
- Diagnostic Pathology Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)
- akta.pro secondary industry
- Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)
Keywords
Where Douglass Hanly Moir Pathology is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices4 records
Markets served
Douglass Hanly Moir Pathology business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Medicare-rebatable pathology tests: Bulk billing for Medicare-eligible outpatient pathology tests, with maximum out-of-pocket cost of $210 per day
- Private billing for specialized tests: Private fees applied for specialized diagnostic procedures, tests not referred under Medicare rules, or tests falling outside Medicare scope
- Direct billing for overseas patients: Direct billing agreements with OSHC and OSV insurers (AHM OSHC, Allianz OSHC, Bupa, Medibank Private) for overseas students and visitors
- Self-funded immunity screening: Self-funded testing program for healthcare employment immunity screening not covered by Medicare
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Drug Testing - Chain of Custody |
| One time/ perpetual license | Pay-as-you-go | Drug and Alcohol Testing |
| One time/ perpetual license | Pay-as-you-go | Active B12 Confirmatory Testing |
| Unit Pricing | Pay-as-you-go | Immunity Screening Tests (Individual) |
| Subscription | Pay-as-you-go | Medicare-eligible outpatient pathology |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
Douglass Hanly Moir Pathology product offering
Product offeringCore offering
Douglass Hanly Moir Pathology operates a comprehensive diagnostic pathology practice delivering routine and specialty pathology testing through more than 500 collection centres, metropolitan and regional laboratories, and a 24/7 central laboratory across New South Wales and north-west Victoria. Services span clinical pathology, genetic testing, prenatal screening, dermatopathology, urological pathology, gynecological pathology, cardiology testing, drug and alcohol screening, and workplace pathology, with results delivered electronically to referring clinicians.
Product overview
Douglass Hanly Moir Pathology (DHM) is a comprehensive diagnostic pathology practice offering a broad portfolio of pathology testing services across New South Wales and north-west Victoria. The service operates through a network structure comprising a Central Laboratory, Metropolitan Laboratories, and Regional Laboratories, all part of the Sonic Healthcare group. The core diagnostic offerings span routine and specialty pathology tests including clinical pathology (blood tests, STI testing, allergy testing), genetic testing (NIPT, karyotyping, PGx, reproductive carrier screening), specialty services (GynaePath, Sonic Skin Dx, Sonic Uro Dx, Sonic Genetics, Cardiology, Gastrointestinal & Hepatic Pathology), and commercial pathology (Drug & Alcohol Testing, Workplace Testing, Health & Wellness Screening). Supporting digital platforms include Sonic Dx for electronic result delivery, eSupplies for supply ordering, Sonic Edu for clinician education, and My Health Record integration. Specialty offerings like MetaPanel (metagenomic GI pathogen testing) and patient comfort technology like Smileyscope (VR headsets) differentiate the service. The organization provides over 500 collection centres, 24-hour operation, and serves general practitioners, medical specialists, private hospitals, nursing homes, and community health services.
Differentiator
Problem solved
Functional benefit
Brands
- GynaePath: Gynaecological pathology services specializing in women's health diagnostics.
- Sonic Skin Dx
- Sonic Uro Dx
- Sonic Genetics
- MetaPanel
- eSupplies
- Sonic Dx
- Sonic Edu
Quantifiable outcome
- Medicare rebate eligible tests with maximum out-of-pocket of $210 per day
- +1 more outcomes
Companies that use Douglass Hanly Moir Pathology
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles4 records
Douglass Hanly Moir Pathology technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Douglass Hanly Moir Pathology partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Sonic HealthcarecoreSonic Healthcare is the parent company of Douglass Hanly Moir Pathology, providing organizational infrastructure and shared resources across the Sonic Healthcare laboratory network.
- AHM OSHCminorDirect billing agreement for Overseas Student Health Cover holders to access DHM pathology services with reduced or no upfront payment.
- Allianz OSHCminorDirect billing agreement for Allianz Overseas Student Health Cover and Overseas Visitor Cover holders (policy must begin with 'P').
- BupaminorDirect billing agreement for Bupa OSHC holders to access DHM pathology services.
- Medibank PrivateminorDirect billing agreement for Medibank Private OSHC/OSV holders to access DHM pathology services.
- SmileyscopeminorPartnership to provide virtual reality headsets at select collection centres to help patients remain calm and comfortable during blood draws and sample collection procedures.
- Sonic DxcoreElectronic results delivery platform for referring clinicians to download pathology results.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Douglass Hanly Moir Pathology competitors and assessment
Company assessmentDirect peers
- Laverty Pathology: A Healius-owned clinical pathology provider with strong NSW and ACT coverage; directly competes with DHM for GP referrals, collection-centre traffic, and specialist anatomical pathology work in overlapping Sydney metro regions.
- Australian Clinical Labs: ASX-listed clinical and anatomical pathology operator with national collection centre footprint; competes head-to-head with DHM on routine diagnostics, genetic testing, and corporate/workplace pathology in NSW and Victoria.
- QML Pathology: Healius-owned pathology network primarily serving Queensland; comparable to DHM in operating model and clinical service depth, providing a benchmark for collection-centre economics and GP referral stickiness.
- Dorevitch Pathology: A Healius pathology brand with deep Victorian coverage including Melbourne metro; overlapping with DHM's Mildura/north-west Victoria footprint and competing for hospital and GP referrals in shared geographies.
- Sullivan Nicolaides Pathology: Sonic Healthcare's flagship Queensland pathology brand and DHM's sister lab; shares group IT, procurement, and Sonic Dx, making it the most operationally analogous peer for benchmarking specialty subdiscipline coverage.
- Melbourne Pathology: Another Sonic Healthcare pathology brand focused on metropolitan Victoria; closely comparable in Medical Leadership model, pathologist-led specialty services, and integrated electronic results platform.
- Western Diagnostic Pathology: Healius pathology brand covering Western Australia; comparable collection-centre and laboratory operating model, useful for benchmarking regional pathology economics versus DHM's non-metro NSW footprint.
- Capital Pathology: Sonic Healthcare pathology brand serving ACT and southern NSW; shares Sonic Dx, Sonic Edu, and group-wide pathology protocols with DHM, making it the closest sister-lab peer in overlapping service area.
- Infinity Pathology: A specialty anatomic and molecular pathology provider aligned with Australian Clinical Labs; competes with DHM's Sonic Skin Dx, GynaePath, and Sonic Uro Dx for specialist dermatopathology and uropathology referrals.
Emerging players
- 4D Path: An emerging digital pathology platform applying AI to pathology workflows; overlaps with DHM at the pathology informatics layer and could either partner or compete as laboratory digital infrastructure evolves.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Douglass Hanly Moir Pathology social profiles
Digital presenceDouglass Hanly Moir Pathology compliance and trust
Trust signalCompliance4 records
Douglass Hanly Moir Pathology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Douglass Hanly Moir Pathology leadership team
Management profileNumber of profiles
Douglass Hanly Moir Pathology subsidiaries and ownership
Company hierarchySubsidiaries6 records
Douglass Hanly Moir Pathology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Douglass Hanly Moir Pathology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Douglass Hanly Moir Pathology
What does Douglass Hanly Moir Pathology do?
Douglass Hanly Moir Pathology operates a comprehensive diagnostic pathology practice delivering routine and specialty pathology testing through more than 500 collection centres, metropolitan and regional laboratories, and a 24/7 central laboratory across New South Wales and north-west Victoria. Services span clinical pathology, genetic testing, prenatal screening, dermatopathology, urological pathology, gynecological pathology, cardiology testing, drug and alcohol screening, and workplace pathology, with results delivered electronically to referring clinicians.
Is Douglass Hanly Moir Pathology a public or private company?
Douglass Hanly Moir Pathology is a private company. It is classified as corporate owned and is currently operating.
When was Douglass Hanly Moir Pathology founded?
Douglass Hanly Moir Pathology was founded in 1996. It employs 501 to 1,000 people.
Where is Douglass Hanly Moir Pathology based?
Douglass Hanly Moir Pathology is headquartered in Sydney, Australia, in the Oceania region.
How does Douglass Hanly Moir Pathology make money?
Four revenue lines are on record. Medicare-rebatable pathology tests are the primary driver. The others are private billing for specialized tests, direct billing for overseas patients and self-funded immunity screening.
Who are Douglass Hanly Moir Pathology's main competitors?
Direct peers on record are Laverty Pathology, Australian Clinical Labs, QML Pathology, Dorevitch Pathology, Sullivan Nicolaides Pathology, Melbourne Pathology, Western Diagnostic Pathology, Capital Pathology and Infinity Pathology. 4D Path is listed as an emerging player.
Does Douglass Hanly Moir Pathology have an API?
No public API is recorded for Douglass Hanly Moir Pathology.
What industry is Douglass Hanly Moir Pathology in?
Douglass Hanly Moir Pathology's product category is Diagnostic Pathology Services. Its primary akta.pro industry code is HLAFAMAA, Anatomic Pathology (Histopathology & Cytopathology), with a secondary code of HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD). Its NAICS code is 621511 and its SIC code is 8071.